ARIXTRA

fondaparinux sodium · Mylan Institutional LLC

Drug timelines are a Plus or Pro feature.

40 regulatory and trial events tracked for ARIXTRA, covering 2008-10-17 to 2026-08-18. Get the full timeline:

Most recent: EMA Authorised: Arixtra (fondaparinux sodium) — Viatris Healthcare Limited